Anette Lindqvist

Anette Lindqvist

Director of Finance/CFO at XBRANE BIOPHARMA AB

Net worth: 5 100 $ as of 2024-03-30

63 year
Health Technology
Commercial Services
Consumer Services

Profile

Anette Lindqvist is currently the Chairman of Nanolyze AB and the Chief Financial Officer & Head-Investor Relations at Xbrane Biopharma AB.
Previously, she worked as a Director at Medivir AB from 2022 to 2023, as well as a Director at CombinedX AB and Head-Business Control at Swedish Orphan Biovitrum AB.
She also held a position as Director-Global Clinical Finance at AstraZeneca AB.
Ms. Lindqvist obtained an undergraduate degree from the University of Gothenburg.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2023-09-04 180,855 ( 0.01% ) 5 100 $ 2024-03-30

Anette Lindqvist active positions

CompaniesPositionStart
XBRANE BIOPHARMA AB Director of Finance/CFO 2021-01-10
Chairman -
All active positions of Anette Lindqvist

Former positions of Anette Lindqvist

CompaniesPositionEnd
MEDIVIR AB Director/Board Member 2023-10-19
SWEDISH ORPHAN BIOVITRUM AB Corporate Officer/Principal -
Corporate Officer/Principal -
COMBINEDX AB Director/Board Member -
See the detail of Anette Lindqvist's experience

Training of Anette Lindqvist

University of Gothenburg Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Anette Lindqvist's experience

Connections

25

1st degree connections

7

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies4
MEDIVIR AB

Health Technology

SWEDISH ORPHAN BIOVITRUM AB

Health Technology

XBRANE BIOPHARMA AB

Health Technology

COMBINEDX AB

Commercial Services

Private companies2

Commercial Services

Commercial Services

See company connections
  1. Stock Market
  2. Insiders
  3. Anette Lindqvist